BIOCON Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > biocon

Technical Analysis

Technical Strength: 7.3 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 68.3. According to RSI analysis, biocon is technically strong. 9.0 BIOCON RSI Chart
MACD (?) MACD: 14.1 and Signal Line: 16.4. According to MACD analysis, biocon is marginally weak. 3.0 BIOCON MACD Chart
Simple Moving Average (?) Price just got above it's 20-day simple moving average which is a positive signal. According to simple moving average analysis, biocon is in a strong uptrend. Major support levels are 543.29, 494.164, 388.1543. 9.0 BIOCON Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, biocon is in a strong uptrend. Major support levels are 538.6301, 499.8888, 406.9569. 10.0 BIOCON Exponential Moving Average Chart
Bollinger Bands (?) Bollinger bandwidth suggests that a squeeze has ended and a brekout above the upper band has happened which is a positive signal. %b is 1.38. According to bollinger bands, biocon has hit the upper band which is a positive signal. 9.0 BIOCON Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 494.8182 and 470.05. Resistance level is 575.0. 6.5 BIOCON Fibonacci Retracement Chart
Average True Range (?) ATR: 16.7 NA BIOCON Average True Range Chart
Average Directional Index (?) ADX is 42.2 which means BIOCON is in a trend. NA BIOCON Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
January 19, 2018
Open Price 549.0
High Price 575.0
Low Price 545.1
Close Price 569.35
Absolute Change 29.75
Percentage Change 5.51%
Weekly Change 5.36%
Monthly Change 5.45%
Yearly Change 71.2%
52-week high 575.0
52-week low 295.033333333
Corporate Actions
ExDate Purpose
July 20, 2017 AGM/DIV-RE 1 PER SHARE
June 15, 2017 BONUS 2:1
June 22, 2016 ANNUAL GENERAL MEETING
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.756
Confidence in Beta5.26%
Market Capital Rs. 11385.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 14.5566666667
TTM Price-to-Earnings (P/E) Ratio 39.1
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 19 January 2018: Deliverable Quantity:1.44e+06 NA BIOCON Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 19 January 2018: Daily Volatility:0.4662 NA BIOCON Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 19 January 2018: PCR_OI:0.516 PCR:0.204 NA BIOCON PCR Chart
Option Pain (?) 19 January 2018: Max Pain:550.0 NA BIOCON Option Pain Chart
Premium (?) 19 January 2018 Premium: -4.25 Futures OI:5956200.0 NA BIOCON Premium Chart
Option_MAX_OI (?) 19 January 2018: Price:569.35 Put with maximum OI:540.0 Call with maximum OI:600.0 NA BIOCON Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
January 25, 2018 565.1 5956200.0 11580.0 12449.0 569.35
February 22, 2018 564.9 2953800.0 1351.0 1688.0 569.35
March 28, 2018 564.0 10800.0 7.0 7.0 569.35

Announcements

December 26, 2017 BiocAnalysts/Institutional Investor Meet/Con. Call Updatescon Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
December 22, 2017 BiocAnalysts/Institutional Investor Meet/Con. Call Updatescon Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
See all Announcements

Board Meetings

Date Meeting Date Purpose
December 22, 2017 January 24, 2018 InteResults/Otherser alia, consider, approve and take on record, the un-audited financial results (both standalone and consolidated) of the Company for the quarter ended December 31, 2017 amongst other routine matters.
September 27, 2017 October 26, 2017 InteResultser alia, consider, approve and take on record, the un-audited financial results (both standalone and consolidated) of the Company for the quarter and half year ended September 30, 2017 amongst other routine matters.
See all Board Meetings

BIOCON is part of...

Index Weightage
NFTYMCAP50 NA

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 521.4 Rs. 533.2 Rs. 551.3 Rs. 563.1 Rs. 581.2 Rs. 593 Rs. 611.1